Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 3
2012 2
2013 2
2014 2
2015 1
2016 2
2019 5
2020 3
2021 4
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors. von Herrath M, et al. Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1. Lancet Diabetes Endocrinol. 2021. PMID: 33662334 Clinical Trial.
Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.
Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K, Honka M, Janez A, Krnic M, Lalic N, Martinka E, Rahelic D, Roman G, Tankova T, Várkonyi T, Wolnik B, Zherdova N. Czupryniak L, et al. Among authors: wolnik b. Diabetes Technol Ther. 2014 Jul;16(7):460-75. doi: 10.1089/dia.2013.0302. Epub 2014 Apr 9. Diabetes Technol Ther. 2014. PMID: 24716890 Free PMC article. Review.
Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.
Akalin S, Berntorp K, Ceriello A, Das AK, Kilpatrick ES, Koblik T, Munichoodappa CS, Pan CY, Rosenthall W, Shestakova M, Wolnik B, Woo V, Yang WY, Yilmaz MT; Global Task Force on Glycaemic Control. Akalin S, et al. Among authors: wolnik b. Int J Clin Pract. 2009 Oct;63(10):1421-5. doi: 10.1111/j.1742-1241.2009.02165.x. Int J Clin Pract. 2009. PMID: 19769698
Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients.
Kubica J, Kubica A, Grzelakowska K, Stolarek W, Grąbczewska Z, Michalski P, Niezgoda P, Bartuś S, Budaj A, Dąbrowski M, Drożdż J, Gellert R, Jaguszewski MJ, Jankowski P, Legutko J, Lesiak M, Leszek P, Małyszko J, Mitkowski P, Nessler J, Pawlaczyk K, Siller-Matula J, Stompór T, Wolnik B, Navarese EP. Kubica J, et al. Among authors: wolnik b. Cardiol J. 2023;30(1):143-149. doi: 10.5603/CJ.a2021.0133. Epub 2021 Oct 28. Cardiol J. 2023. PMID: 34708866 Free PMC article.
Cerebral and skin microcirculatory dysfunction in type 1 diabetes.
Kozera GM, Neubauer-Geryk J, Wolnik B, Szczyrba S, Wojczal J, Nyka WM, Bieniaszewski L. Kozera GM, et al. Among authors: wolnik b. Postepy Dermatol Alergol. 2019 Feb;36(1):44-50. doi: 10.5114/ada.2018.81185. Epub 2019 Jan 11. Postepy Dermatol Alergol. 2019. PMID: 30858778 Free PMC article.
Angiogenin in middle-aged type 1 diabetes patients.
Neubauer-Geryk J, Kozera GM, Wolnik B, Szczyrba S, Nyka WM, Bieniaszewski L. Neubauer-Geryk J, et al. Among authors: wolnik b. Microvasc Res. 2012 Nov;84(3):387-9. doi: 10.1016/j.mvr.2012.08.005. Epub 2012 Aug 30. Microvasc Res. 2012. PMID: 22940420
Above 40% of Polish children and young adults with type 1 diabetes achieve international HbA1c target - results of a nationwide cross-sectional evaluation of glycemic control: The PolPeDiab HbA1c study.
Szadkowska A, Baranowska-Jaźwiecka A, Michalak A, Jarosz-Chobot P, Myśliwiec M, Głowińska-Olszewska B, Szypowska A, Nazim J, Mazur A, Szalecki M, Skowrońska B, Kucharska-Zubkiewicz A, Beń-Skowronek I, Walczak M, Klupa T, Wolnik B, Zozulińska-Ziółkiewicz D, Młynarski W; PolPeDiab HbA1c Study Group. Szadkowska A, et al. Among authors: wolnik b. Pediatr Diabetes. 2021 Nov;22(7):1003-1013. doi: 10.1111/pedi.13250. Epub 2021 Aug 4. Pediatr Diabetes. 2021. PMID: 34351670
27 results